Passage Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Passage Bio
PASG Stock  USD 9.11  1.46  13.81%   
Passage Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Passage Bio's valuation are provided below:
Market Capitalization
34.9 M
Earnings Share
(13.58)
There are over one hundred nineteen available trending fundamental ratios for Passage Bio, which can be analyzed over time and compared to other ratios. Active traders should verify all of Passage Bio recent fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Passage Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Passage Bio's main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 2.7 M or Depreciation And Amortization of 2.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.53. Passage financial statements analysis is a perfect complement when working with Passage Bio Valuation or Volatility modules.
  
Build AI portfolio with Passage Stock
Check out the analysis of Passage Bio Correlation against competitors.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.

Passage Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets218.7 M117.8 M117.4 M
Slightly volatile
Other Current Liabilities12.1 M17.2 M6.3 M
Slightly volatile
Total Current Liabilities17.1 M22.3 M8.9 M
Slightly volatile
Other Liabilities8.4 M8 M3.9 M
Slightly volatile
Property Plant And Equipment Net19.7 M26.6 M10.1 M
Slightly volatile
Accounts Payable810.6 K853.3 K1.5 M
Slightly volatile
Cash61.9 M33.8 M49.2 M
Slightly volatile
Non Current Assets Total24.1 M27.1 M12.1 M
Slightly volatile
Non Currrent Assets Other395.9 K416.7 K1.7 M
Pretty Stable
Cash And Short Term Investments135.4 M69.1 M93.4 M
Slightly volatile
Common Stock Shares Outstanding2.5 M3.5 M1.8 M
Slightly volatile
Liabilities And Stockholders Equity218.7 M117.8 M117.4 M
Slightly volatile
Non Current Liabilities Total14.1 M19.6 M30.6 M
Slightly volatile
Other Current Assets1.8 M1.9 M7.2 M
Slightly volatile
Other Stockholder Equity514.7 M828.6 M272.1 M
Slightly volatile
Total Liabilities36.5 M47.3 M40.1 M
Slightly volatile
Property Plant And Equipment Gross19.2 M37.8 M10.6 M
Slightly volatile
Total Current Assets141.2 M70.9 M100.9 M
Slightly volatile
Net Working Capital50.8 M53.5 M88 M
Slightly volatile
Common Stock4.7 K6.9 K3.4 K
Slightly volatile
Property Plant Equipment27.2 M25.9 M8.7 M
Slightly volatile
Common Stock Total Equity4.7 K5.8 K3.8 K
Slightly volatile
Deferred Long Term Liabilities171 K180 K1.1 M
Slightly volatile
Non Current Liabilities Other46.8 K36.9 K61.7 K
Slightly volatile
Net Receivables4.9 M3.8 M6.8 M
Slightly volatile
Short Term Investments33.5 M35.3 M141.8 M
Slightly volatile
Capital Surpluse676.8 M798.9 M556.9 M
Slightly volatile
Short and Long Term Debt Total21 M22.9 M26.4 M
Slightly volatile
Short Term Debt3.8 M4.2 M3.4 M
Slightly volatile

Passage Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.6 M2.8 M6.4 M
Slightly volatile
Interest Expense2 M2 M1.6 M
Slightly volatile
Selling General Administrative33.6 M28.7 M16.7 M
Slightly volatile
Other Operating Expenses103.4 M81 M55.9 M
Slightly volatile
Research Development66.9 M46.2 M36 M
Slightly volatile
Total Operating Expenses102.3 M81 M53.8 M
Slightly volatile
Cost Of Revenue2.4 M3.5 M1.2 M
Slightly volatile
Non Recurring4.4 M3.5 M2.1 M
Slightly volatile
Selling And Marketing Expenses3.8 M4.2 M4.6 M
Slightly volatile

Passage Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation2.1 M3.5 M1.2 M
Slightly volatile
Other Non Cash Items4.1 M3.3 M3.8 M
Slightly volatile
Capital Expenditures29.1 K30.6 K3.4 M
Very volatile
Change To Account Receivables335.5 K457.7 K299.4 K
Slightly volatile
Issuance Of Capital Stock7.5 M7.9 M59.3 M
Very volatile
End Period Cash Flow61.9 M33.8 M49.2 M
Slightly volatile
Change To Netincome17.7 M21.8 M10.6 M
Slightly volatile
Stock Based Compensation5 M5.2 M6.3 M
Slightly volatile
Sale Purchase Of Stock82.9 K87.3 K277.5 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.01210.01278.6193
Slightly volatile
Payables Turnover2.32.582.8165
Slightly volatile
Cash Per Share27.7629.2345.0127
Slightly volatile
Days Payables Outstanding102115125
Slightly volatile
Income Quality0.960.851.1498
Slightly volatile
Current Ratio4.454.6863.6067
Slightly volatile
Debt To Equity0.210.370.1754
Slightly volatile
Capex Per Share0.01230.01291.934
Pretty Stable
Interest Debt Per Share10.269.79.8522
Slightly volatile
Debt To Assets0.140.220.1312
Slightly volatile
Days Of Payables Outstanding102115125
Slightly volatile
Ebt Per Ebit1.111.060.991
Slightly volatile
Total Debt To Capitalization0.160.260.144
Slightly volatile
Debt Equity Ratio0.210.370.1754
Slightly volatile
Quick Ratio4.454.6863.6067
Slightly volatile
Cash Ratio2.122.2346.6022
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.171.151.1097
Slightly volatile
Debt Ratio0.140.220.1312
Slightly volatile

Passage Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.1 M67.6 M73.8 M
Slightly volatile
Enterprise Value54.1 M60.9 M66.4 M
Slightly volatile

Passage Fundamental Market Drivers

Passage Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Passage Bio Financial Statements

Passage Bio stakeholders use historical fundamental indicators, such as Passage Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Passage Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Passage Bio's assets and liabilities are reflected in the revenues and expenses on Passage Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Passage Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue3.5 M2.4 M

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:
How To Invest In Passage
Details
Is Passage Stock a good investment?
Details
What is Passage Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Passage Bio Correlation against competitors.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Can Biotechnology industry sustain growth momentum? Does Passage have expansion opportunities? Factors like these will boost the valuation of Passage Bio. Anticipated expansion of Passage directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Passage Bio demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(13.58)
Return On Assets
(0.32)
Return On Equity
(0.87)
Investors evaluate Passage Bio using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Passage Bio's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Passage Bio's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Passage Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Passage Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Passage Bio's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY